Alterations of bile acids involved in the synthesis pathway in HD
Schematic representation of the alterations of bile acids involved in the synthesis pathway in HD. Primary bile acids are converted to secondary bile acids by the gut microbiome. 24(S)-hydroxycholesterol from the brain mainly involves the alternative pathway. GCDCA and GUDCA levels are elevated and iso-LCA decreased in Huntington’s disease patients (HD) (presymptomatic HD (preHD) + symptomatic HD (symHD), and the total of neurotoxic bile acids (GCA + GDCA + GCDCA) is higher in symHD compared to healthy controls (HC). Conversely, the sum of neuroprotective BAs (UDCA + GUDCA + TUDCA) is increased in preHD carriers compared to HC. Also, it is noted that decreased CYP46A1 and 24(S)-hydroxycholesterol levels in HD have been shown in previously published papers. Abbreviations: CA, cholic acid; CDCA, chenodeoxycholic acid; TCA, taurocholic acid; GCA, glycocholic acid; TCDCA, taurochenodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; DCA, deoxycholic acid; LCA, lithocholic acid; UDCA, ursodeoxycholic acid; TDCA, taurodeoxycholic acid; GDCA, glycodeoxycholic acid; TUDCA, tauroursodeoxycholic acid; GUDCA, glycoursodeoxycholic acid; Iso-LCA, Isolithocholic acid
Publication
Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington’s Disease (2024) Ping-I Chiang, et al. Metabolites. 2024 Jul;14(7). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CYP7A1 | CYP7A1 | ncbigene_symbol | CYP7A1 | 1581 |
| Homo sapiens | Primates | CYP27A1 | CYP27A1 | ncbigene_symbol | CYP27A1 | 1593 |
| Homo sapiens | Primates | CYP46A1 | CYP46A1 | ncbigene_symbol | CYP46A1 | 10858 |
| Homo sapiens | Primates | CYP8B1 | CYP8B1 | ncbigene_symbol | CYP8B1 | 1582 |
| Homo sapiens | Primates | CYP7B1 | CYP7B1 | ncbigene_symbol | CYP7B1 | 9420 |
| Homo sapiens | Primates | CYP39A1 | CYP39A1 | ncbigene_symbol | CYP39A1 | 51302 |
| Homo sapiens | Primates | GCA | GCA | ncbigene_symbol | GCA | 25801 |
| Homo sapiens | Primates | DCA | DCA | ncbigene_synonym | HLA-DQA2 | 3118 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | CLTA | 1211 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | GUCY2D | 3000 |
| Homo sapiens | Primates | LCA | LCA | ncbigene_synonym | PTPRC | 5788 |
| Homo sapiens | Primates | GDCA | GDCA | ncbigene_synonym | GNAT3 | 346562 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Cholesterol | cholesterol | cholesterol | chebi:16113 | |
| CDCA | CDCA | 3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid | chebi:16755 | |
| TCA | TCA | trichloroacetic acid | chebi:30956 | |
| GCA | GCA | chebi:139037 | ||
| GUDCA | GUDCA | N-(3alpha,7beta-dihydroxy-5beta-cholan-24-oyl)glycine | chebi:89929 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|